SLS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 20:55):
Our systems believe the stock currently is undervalued by 0.23% compare to its pairs and should correct upwards.

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States...

Stats
Dagens volum	527 106
Gjennomsnittsvolum	1.40M
Markedsverdi	65.84M
EPS	$-0.210 ( Q1 \| 2024-03-31 )
Neste inntjeningsdato	( $-0.160 ) 2024-08-08
Last Dividend	$0.420 ( 2010-12-09 )
Next Dividend	$0 ( N/A )
P/E	-1.060 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00600 (0.53%)

AADI -6.47%

ABCL 1.83%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 4.21%

ABSI 4.58%

ABUS -0.66%

ABVX -3.00%

ACAD 0.00%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.00%

ACLX 0.16%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.70%

ADGI 0.87%

ADIL -1.70%

ADMA -1.82%

ADPT 0.74%

ADTX -2.78%

ADVM 1.30%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.36%

AGIO -2.01%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.13%

AKRO -2.55%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.86%

ALLK -11.44%

ALLO -3.97%

ALLR -2.55%

ALNA 3.16%

ALNY 1.82%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -14.17%

ALVR -0.69%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.17%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.97%

ANPC -3.15%

APGE 0.80%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.87%

APLT -0.45%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.01%

ARDS -12.13%

ARDX 0.83%

ARGX -0.43%

ARNA 0.00%

ARPO -0.90%

ARQT -2.86%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.82%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -1.86%

ATAI -3.70%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.85%

ATRA -3.60%

ATXI 2.70%

ATXS -0.89%

AUPH -0.90%

AURA 4.86%

AUTL -3.30%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.00%

AVTX -3.74%

AVXL -5.06%

AXLA 0.00%

AXSM -1.20%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.10%

BCAB -3.27%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.98%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.95%

BDRX -2.54%

BDTX 0.00%

BEAM 2.56%

BFRA -2.91%

BGNE -2.18%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.14%

BLU 0.03%

BLUE -2.28%

BMEA -13.51%

BMRN 0.45%

BNOX 6.15%

BNTC -1.69%

BNTX -1.72%

BOLD -7.90%

BOLT -0.05%

BPMC -1.48%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 12.81%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.01%

CADL 0.80%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.77%

CDXS 9.66%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.31%

CGON -1.43%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.72%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -36.09%

CNST 0.00%

CNTA 0.11%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.60%

COYA 1.14%

CPRX -1.75%

CRBP -0.93%

CRBU -7.10%

CRDF 2.20%

CRGX 0.10%

CRIS -1.59%

CRNX -6.23%

CRSP -0.06%

CRTX 2.63%

CRVO -3.23%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.33%

CUE -1.73%

CVAC -7.34%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.56%

CYTO 0.00%

DARE 3.54%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.58%

DNLI -1.90%

DNTH -4.87%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.09%

EFTR 5.35%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.24%

ELOX 10.77%

ELTX -5.15%

ELVN -2.14%

ELYM 5.12%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.94%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.09%

EXAI -0.19%

EXEL 0.58%

EYEG -0.69%

EYEN 0.59%

EYPT 1.69%

FATE -11.71%

FBIO 0.65%

FBIOP 0.87%

FBLG -7.29%

FBRX -0.02%

FDMT -4.93%

FENC -2.26%

FGEN -9.83%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.33%

FULC 2.17%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.78%

GMAB -0.39%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -3.40%

GNTA 3.94%

GOSS -10.69%

GOVX -1.82%

GOVXW 10.89%

GPCR -6.41%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.59%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.56%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -0.99%

HOOK 1.67%

HOTH -1.10%

HOWL 1.71%

HRMY 5.05%

HRTX 8.87%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.57%

ICCC -3.10%

ICPT 0.21%

ICU 16.95%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.18%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.58%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -6.90%

IMNM 4.42%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.04%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -0.71%

INBX -2.66%

INCY -2.22%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 1.46%

INMB 4.97%

INO 1.95%

INSM -1.00%

INTS -1.96%

INVA 0.28%

INZY 2.29%

IOBT -10.94%

IONS 1.69%

IOVA -2.66%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.54%

ISEE 0.38%

ITOS 1.47%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.58%

JAZZ -0.81%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -5.47%

KALV -3.55%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.71%

KPRX -2.16%

KPTI -8.59%

KRBP -10.00%

KRON 1.58%

KROS -0.32%

KRRO -2.30%

KRTX 0.03%

KRYS 0.51%

KTRA 11.86%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.87%

KYTX -3.88%

KZIA 4.41%

KZR -0.15%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.02%

LENZ -1.93%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.78%

LPCN -3.68%

LPTX -2.75%

LQDA 0.41%

LRMR 0.71%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -2.06%

LYEL -35.29%

LYRA 1.47%

MACK 0.10%

MBIO -11.36%

MBRX -1.43%

MCRB 3.08%

MDGL -2.32%

MDNA -13.16%

MDWD 3.56%

MDXG -2.14%

MEIP 0.00%

MESO -1.71%

MGNX -4.78%

MGTA -7.74%

MGTX -0.79%

MGX 2.14%

MIRM 0.51%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -6.08%

MNKD -0.67%

MNMD 3.75%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.72%

MREO -1.86%

MRKR -0.43%

MRNA -9.08%

MRNS -5.62%

MRSN -2.86%

MRTX -0.17%

MRUS -0.53%

MRVI 0.36%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.27%

NKTX -3.75%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.49%

NMTR -42.97%

NOVN -24.84%

NRBO 15.73%

NRIX -0.53%

NRSN -4.82%

NRSNW 0.00%

NRXP -8.27%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.38%

NTRBW -31.07%

NUVL -0.87%

NVAX -7.64%

NVCT -7.49%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.05%

OCS -1.00%

OCUL 1.07%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -4.86%

OMER -2.31%

OMGA 0.63%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.34%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.67%

OVID 0.63%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX 0.04%

PDSB -6.65%

PEPG 1.19%

PGEN -6.30%

PHAR 2.19%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.74%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.87%

PRAX 7.30%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.74%

PRTC 0.62%

PRTG 4.25%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.61%

PTE -0.82%

PTGX -1.03%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 4.09%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -31.32%

QSIAW -3.13%

QTTB 1.83%

QURE -0.78%

RAIN -1.63%

RANI 4.81%

RAPT -1.30%

RARE 1.66%

RCKT -9.97%

REGN -0.30%

RENB -3.43%

REPL -1.26%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.66%

RIGL -6.24%

RLAY -4.60%

RLMD 0.00%

RLYB -4.35%

RNA 1.85%

RNAC -4.53%

RNAZ -1.92%

RNXT 1.79%

ROIV -1.75%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.58%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.59%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.86%

RYTM -6.20%

RYZB 0.02%

RZLT 3.62%

SABS -1.37%

SABSW -11.81%

SAGE -0.18%

SANA -2.31%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.85%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.48%

SGMT -5.08%

SGTX -2.56%

SIOX 22.63%

SLDB -2.93%

SLGL 5.23%

SLN -6.62%

SLNO 0.74%

SLRX 1.21%

SLS -2.56%

SMMT -3.25%

SNDX 3.33%

SNGX -0.38%

SNPX -2.55%

SONN -2.15%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.13%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.51%

STSA 0.00%

STTK 7.17%

SURF -0.93%

SVRA -0.50%

SWTX 0.22%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -7.16%

TARS -2.00%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 1.37%

TCRR 0.00%

TCRT -1.75%

TCRX 5.33%

TECH -0.86%

TENX -0.32%

TERN -8.27%

TFFP -7.61%

TGTX -7.14%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.46%

TNXP -6.81%

TNYA -4.03%

TPST 5.83%

TRDA -4.67%

TRVI 3.07%

TRVN 0.80%

TSHA -18.90%

TSVT -3.99%

TTNP -6.05%

TVTX 3.14%

TYRA -6.65%

UBX -2.13%

UNCY -4.00%

URGN 2.24%

UTHR -0.06%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 1.04%

VCNX 9.03%

VCYT -0.75%

VERA -5.34%

VERU 2.62%

VERV -2.39%

VIGL -1.87%

VINC 2.93%

VIR -0.92%

VIRI -5.72%

VIRX 3.98%

VKTX -1.78%

VLON -13.04%

VNDA -3.91%

VOR -6.05%

VRCA 0.28%

VRDN -3.76%

VRNA -1.60%

VRPX 1.02%

VRTX 0.07%

VSTM 3.91%

VTGN -1.51%

VTVT 0.39%

VTYX -2.72%

VXRT -1.93%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.91%

XBIO 1.03%

XBIT 6.89%

XCUR 3.77%

XENE -1.76%

XERS 4.77%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.31%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-01-22	Stergiou Angelos M.	Buy	159 000	Common Stock
2024-01-22	Stergiou Angelos M.	Buy	238 500	Stock Option (Right to Buy)
2024-01-22	Scheinberg David A	Buy	6 000	Common Stock
2024-01-22	Scheinberg David A	Buy	10 000	Stock Option (Right to Buy)
2024-01-22	Wood Barbara A	Buy	35 000	Common Stock

INSIDER POWER
95.64
Last 98 transactions
Buy: 3 194 450 \| Sell: 76 679

Korrelasjon (AI algo v.1.1b): Undervalued: 0.23% $1.143 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.17 (neutral)

Kort: 0.27 (neutral)

Signal:(57.143) Neutral

Sellas Life Sciences Korrelasjon

10 Mest positive korrelasjoner
CEG	0.903
IINN	0.899
VNOM	0.893
FANG	0.889
PWP	0.884
APP	0.883
MTEK	0.881
BLIN	0.878
WING	0.877
EVBG	0.877

10 Mest negative korrelasjoner
SOFO	-0.908
FXNC	-0.903
COMM	-0.896
WKME	-0.896
PDCO	-0.895
AIRS	-0.893
CNTG	-0.892
AKAN	-0.889
GMBLP	-0.888
SFST	-0.887

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sellas Life Sciences Korrelasjon - Valuta/Råvare

-0.65
( weak negative )

-0.52
( weak negative )

0.00
( neutral )

0.56
( weak )

-0.60
( weak negative )

Sellas Life Sciences Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.340

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.340

FY	2022
Omsetning:	$1.00M
Bruttogevinst:	$900 000 (90.00 %)
EPS:	$-2.10

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$-200 000 (0.00 %)
EPS:	$-2.60

Financial Reports:

No articles found.

Sellas Life Sciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Sellas Life Sciences Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.150	2010-09-09
Last Dividend	$0.420	2010-12-09
Next Dividend	$0	N/A
Payout Date	2010-12-20
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.570	--
Avg. Dividend % Per Year	0.00%	--
Score	1.52	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-08-08)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.52

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2010	$0.570	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
09 Dec 2010	$0.420	30 Nov -0001	30 Nov -0001	20 Dec 2010
09 Sep 2010	$0.150	07 Sep 2010	30 Nov -0001	22 Sep 2010

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-1.466	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-52.58	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.489	0.800	7.55	6.04	[1 - 3]
quickRatioTTM	1.282	0.800	7.16	5.73	[0.8 - 2.5]
cashRatioTTM	1.282	1.500	3.99	5.98	[0.2 - 2]
debtRatioTTM	0.0328	-1.500	9.45	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.670	2.00	-0.223	-0.447	[0 - 30]
freeCashFlowPerShareTTM	-0.860	2.00	-0.430	-0.860	[0 - 20]
debtEquityRatioTTM	0.0827	-1.500	9.67	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-37.51	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.367

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.464	1.000	-0.249	0	[1 - 100]
returnOnEquityTTM	-52.58	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.860	2.00	-0.287	-0.860	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.670	2.00	-0.223	-0.447	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0284	1.500	-3.52	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.905

Sellas Life Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Sellas Life Sciences

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York.